Nader Hayaux & Goebel has advised Corporación Andina de Fomento (CAF) on an investment in favour of Patia Biopharma, which will be used to develop the “DIABEVID” test, a cost-effective genetic test to identify
Nader Hayaux & Goebel has advised Corporación Andina de Fomento (CAF) on an investment in favour of Patia Biopharma, which will be used to develop the “DIABEVID” test, a cost-effective genetic test to identify